T2 Biosystems Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2012
Net Income	-50.08	-62.33	-49.24	-46.8	-59.01	-51.15	-62.43	-54.8	-45.29	-35.96	Upgrade
Depreciation & Amortization	2.21	2.27	2.54	3.16	3.64	2.45	2.94	2.28	1.47	0.69	Upgrade
Share-Based Compensation	4.35	6.49	7.09	3.91	5.46	9.9	4.79	4.85	4.17	1.65	Upgrade
Other Operating Activities	-4.62	2.61	0.74	-3.49	4.55	-1.33	6.98	1.23	2.19	0.86	Upgrade
Operating Cash Flow	-48.14	-50.63	-38.87	-43.22	-45.36	-40.14	-47.72	-46.44	-37.47	-28.18	Upgrade
Capital Expenditures	-0.19	-0.34	-0.46	-0.8	-0.76	-0.59	-2.48	-5.49	-7.97	-2.08	Upgrade
Change in Investments	0	10	25.25	-35.46	0	0	0	0	0	0	Upgrade
Other Investing Activities	-	-	-	-	-	-	-	-	0.08	-	Upgrade
Investing Cash Flow	-0.19	9.66	24.79	-36.26	-0.76	-0.59	-2.48	-5.49	-7.89	-2.08	Upgrade
Share Issuance / Repurchase	52.75	29.08	20.54	85.61	7.23	51.2	19.7	0.63	35.48	58.24	Upgrade
Debt Issued / Paid	0	0	0	0	-0.88	-1.55	-1.19	11.4	9.69	15.68	Upgrade
Other Financing Activities	-0.06	-0.03	-	-	-	-	-	39.72	-	-	Upgrade
Financing Cash Flow	52.69	29.05	20.54	85.61	6.35	49.66	18.51	51.76	45.17	73.92	Upgrade
Net Cash Flow	4.36	-11.92	6.45	6.13	-39.77	8.93	-31.69	-0.17	-0.19	43.65	Upgrade
Free Cash Flow	-48.33	-50.97	-39.33	-44.02	-46.12	-40.73	-50.19	-51.93	-45.44	-30.27	Upgrade
Free Cash Flow Margin	-671.88%	-228.50%	-140.19%	-242.77%	-553.35%	-387.91%	-1075.74%	-1272.77%	-1615.32%	-25435.29%	Upgrade
Free Cash Flow Per Share	-18.52	-999.31	-1238.00	-1813.83	-5067.49	-5021.23	-7810.71	-9980.30	-11081.74	-17445.67	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).